Gene info: ID 2167

Gene: FABP4

GENE ID: 2167

Synonyms: A-FABP|AFABP|ALBP|HEL-S-104|aP2

Description: fatty acid binding protein 4

Gene type: protein-coding

Location: 8q21.13

dbXrefs: Ensembl:ENSG00000170323 MIM:600434 Vega:OTTHUMG00000164602 UniprotKB:P15090

RefSeq: NC_000008.11

Retrived from: PubMed

SNPs: 0 ANCO-SNPs

Phenotype: ND

# Publications: 2

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 2.581e-1 (AD) 7.587e-2 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
ADIPOQ	0.728
CIDEC	0.653
PLA2G2A	0.631
ADH1B	0.578
CD36	0.568
LEP	0.536
CD300LG	0.519
KRT1	0.512
FLG2	0.504
GATA3	0.498

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
ISLR2	-0.341
GRM4	-0.336
DSCAML1	-0.335
ZNF835	-0.334
RNFT2	-0.333
HIC2	-0.331
ASIC2	-0.325
CACNA2D2	-0.324
LHFPL5	-0.324
CHST5	-0.324

ID	Drug Name	Drug Type	CAS Num	Status	Role
DB02153	3-Sulfinoalanine	Small Molecule	1115-65-7	Experimental	Carrier
DB02776	1-Hexadecanosulfonic Acid	Small Molecule	15015-81-3	Experimental	Carrier
DB03009	2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One	Small Molecule		Experimental	Carrier
DB03766	Propanoic Acid	Small Molecule	79-09-4	Experimental	Carrier
DB03796	Palmitic Acid	Small Molecule	57-10-3	Approved\|Experimental	Carrier
DB03851	Carbazole Butanoic Acid	Small Molecule		Experimental	Carrier
DB04224	Oleic Acid	Small Molecule	112-80-1	Approved\|Investigational	Carrier
DB04437	Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline	Small Molecule		Experimental	Carrier
DB04474	1-Anilino-8-Naphthalene Sulfonate	Small Molecule		Experimental	Carrier
DB04557	Arachidonic Acid	Small Molecule	506-32-1	Experimental	Carrier
DB07283	9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid	Small Molecule		Experimental	Carrier
DB07945	5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid	Small Molecule		Experimental	Carrier
DB08607	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	Small Molecule		Experimental	Carrier

ID	Drug Name	Action	PubMed
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Tretinoin] results in increased expression of FABP4 mRNA"	16573735
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of FABP4 mRNA"	16573735
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of FABP4 mRNA"	12021203\|9543393
C548651	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of FABP4 mRNA	19933214
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of FABP4 mRNA"	24559133
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of FABP4 mRNA"	22763116
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of FABP4 mRNA"	22763116
C558395	2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone	"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of FABP4 mRNA]"	21315688
C014024	2,4,5,2',4',5'-hexachlorobiphenyl	"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FABP4 mRNA"	22262711
C010914	2,4-diaminotoluene	"2,4-diaminotoluene results in decreased expression of FABP4 mRNA"	22016648
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA]	15659569
C006593	2-anthramine	2-anthramine results in increased expression of FABP4 mRNA	23038007
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]	17602619
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of FABP4 mRNA]	18577375
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of FABP4 mRNA	20863820
C023035	3,4,5,3',4'-pentachlorobiphenyl	"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FABP4 mRNA"	22262711\|2530449
C005975	3,4-dihydroxyphenylethanol	"3,4-dihydroxyphenylethanol results in decreased expression of FABP4 mRNA"	21569430
C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid	"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of FABP4 mRNA"	15583048
C520164	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased expression of FABP4 mRNA	15273253
C520164	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
C009505	4,4'-diaminodiphenylmethane	"4,4'-diaminodiphenylmethane results in increased expression of FABP4 mRNA"	18648102
C097470	4'-methoxychalcone	4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of FABP4 mRNA]	28528971
C097470	4'-methoxychalcone	4'-methoxychalcone analog results in increased expression of FABP4 mRNA	28528971
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide results in increased expression of FABP4 mRNA"	15273253
C573233	5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one	"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of FABP4 mRNA"	24646949
C573233	5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one	"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of FABP4 protein"	24646949
C055656	8-((4-chlorophenyl)thio)cyclic-3',5'-GMP	"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of FABP4 protein"	20471953
C055656	8-((4-chlorophenyl)thio)cyclic-3',5'-GMP	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of FABP4 protein]"	20471953
C090860	8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of FABP4 protein]"	20471953
C090860	8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of FABP4 protein]"	20471953
D000082	Acetaminophen	Acetaminophen results in decreased expression of FABP4 mRNA	21420995
D000082	Acetaminophen	Acetaminophen affects the expression of FABP4 mRNA	17562736
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]	27117918
C033116	acetyl methyl tetramethyl tetralin	acetyl methyl tetramethyl tetralin results in increased expression of FABP4 mRNA	24155963
D016604	Aflatoxin B1	Aflatoxin B1 affects the expression of FABP4 protein	20106945
D016604	Aflatoxin B1	Aflatoxin B1 results in increased expression of FABP4 mRNA	23630614
C121227	AL 8810	AL 8810 results in increased expression of FABP4 mRNA	21236357
C518327	aloe emodin	aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA]	22645054
D013196	Dihydrotestosterone	bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein]	18801408
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of FABP4 mRNA	18801408
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of FABP4 protein	18801408
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of FABP4 mRNA	16483693
C023650	aniline	aniline results in increased expression of FABP4 mRNA	22016648
D001151	Arsenic	Arsenic affects the methylation of FABP4 gene	25304211
D001205	Ascorbic Acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	25932594
D001205	Ascorbic Acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA	25062436
D001205	Ascorbic Acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA	25062436
C006680	baicalein	baicalein results in decreased expression of FABP4 protein	24560969
D001553	Benzbromarone	Benzbromarone results in increased expression of FABP4 mRNA	19048458
D001554	Benzene	Benzene results in increased expression of FABP4 mRNA	12928149
D001554	Benzene	TRP53 protein affects the reaction [Benzene results in increased expression of FABP4 mRNA]	12928149
C006703	benzo(b)fluoranthene	benzo(b)fluoranthene results in decreased expression of FABP4 mRNA	26377693
D019324	beta-Naphthoflavone	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FABP4 mRNA	18164116
D001572	Benzofurans	Benzofurans results in decreased expression of FABP4 mRNA	20863820
C022921	benzo(k)fluoranthene	benzo(k)fluoranthene results in decreased expression of FABP4 mRNA	26377693
D001564	Benzo(a)pyrene	AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of FABP4 mRNA]	15034205
D001564	Benzo(a)pyrene	[Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA	26271895
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of FABP4 mRNA	19770486\|2222880
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of FABP4 mRNA	15034205
C057775	benzylparaben	benzylparaben results in increased expression of FABP4 mRNA	22956630
C057775	benzylparaben	benzylparaben results in increased expression of FABP4 mRNA	22956630\|2765973
D001599	Berberine	Berberine results in decreased expression of FABP4 mRNA	26478571
D019207	beta Carotene	beta Carotene results in decreased expression of FABP4 mRNA	21569430
D004958	Estradiol	Estradiol results in decreased expression of FABP4 mRNA	25878060
D004958	Estradiol	Estradiol results in decreased expression of FABP4 mRNA	16643890
D004958	Estradiol	Estradiol results in increased expression of FABP4 mRNA	15713686\|1948475
C031463	beta-glycerophosphoric acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	25932594
C031463	beta-glycerophosphoric acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA	25062436
C031463	beta-glycerophosphoric acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA	25062436
C095105	bexarotene	bexarotene results in increased expression of FABP4 mRNA	25932594
C095105	bexarotene	bexarotene results in increased expression of FABP4 protein	21622945
D001629	Bezafibrate	Bezafibrate results in increased expression of FABP4 mRNA	12759900
D001629	Bezafibrate	Bezafibrate results in increased expression of FABP4 mRNA	21324916
D001629	Bezafibrate	PPARA protein affects the reaction [Bezafibrate results in increased expression of FABP4 mRNA]	21324916
D001629	Bezafibrate	Bezafibrate results in increased expression of FABP4 mRNA	11473052
C053541	bicalutamide	bicalutamide inhibits the reaction [Dihydrotestosterone results in decreased expression of FABP4 protein]	18801408
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased expression of FABP4 mRNA"	23014847
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"PPARG mutant form inhibits the reaction [bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased expression of FABP4 mRNA]"	23014847
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 mRNA	27003841\|2768578
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein	27003841
C543008	bis(4-hydroxyphenyl)sulfone	fulvestrant inhibits the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein]	27003841
C543008	bis(4-hydroxyphenyl)sulfone	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C543008	bis(4-hydroxyphenyl)sulfone	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C543008	bis(4-hydroxyphenyl)sulfone	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
C543008	bis(4-hydroxyphenyl)sulfone	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 mRNA	28938450
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 mRNA	24418828\|2587806
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 protein	24418828
C006780	bisphenol A	fulvestrant inhibits the reaction [bisphenol A results in increased expression of FABP4 protein]	24418828
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 mRNA	24586524
C006780	bisphenol A	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA]	15659569
C006780	bisphenol A	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C006780	bisphenol A	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C006780	bisphenol A	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
C006780	bisphenol A	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
C006780	bisphenol A	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
C006780	bisphenol A	bisphenol A promotes the reaction [CEBPB protein results in increased expression of FABP4 mRNA]	25068083
C006780	bisphenol A	bisphenol A promotes the reaction [Dexamethasone results in increased expression of FABP4 protein]	25068083
C006780	bisphenol A	bisphenol A promotes the reaction [[NR3C1 protein co-treated with CEBPB protein] results in increased expression of FABP4 mRNA]	25068083
C006780	bisphenol A	bisphenol A promotes the reaction [[NR3C1 protein co-treated with CEBPD protein] results in increased expression of FABP4 mRNA]	25068083
C006780	bisphenol A	bisphenol A promotes the reaction [NR3C1 protein results in increased expression of FABP4 mRNA]	25068083
C006780	bisphenol A	bisphenol A results in increased expression of FABP4	26942597
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 mRNA	15659569\|2370495
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 protein	25068083\|2714500
C006780	bisphenol A	INS1 protein affects the reaction [bisphenol A results in increased expression of FABP4 mRNA]	25068083
C006780	bisphenol A	INS1 protein affects the reaction [bisphenol A results in increased expression of FABP4 protein]	25068083
C006780	bisphenol A	Mifepristone inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA]	27145005
C006780	bisphenol A	bisphenol A results in increased expression of FABP4 mRNA	28938450
C006780	bisphenol A	bisphenol A affects the expression of FABP4 mRNA	25181051
C006780	bisphenol A	bisphenol A results in decreased expression of FABP4 mRNA	26088557
C006780	bisphenol A	[Fructose co-treated with bisphenol A] results in increased expression of FABP4 protein	26930160
C512161	bisphenol A glucuronide	bisphenol A glucuronide results in increased expression of FABP4 protein	26018136
C512161	bisphenol A glucuronide	bisphenol A glucuronide results in increased expression of FABP4 protein	26018136
C512161	bisphenol A glucuronide	fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of FABP4 protein]	26018136
C032688	boric acid	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
C032688	boric acid	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
C032688	boric acid	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
C027561	butylbenzyl phthalate	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FABP4 mRNA	26820058
C027561	butylbenzyl phthalate	butylbenzyl phthalate results in increased expression of FABP4 mRNA	24155963\|2792377
C038091	butylparaben	butylparaben results in increased expression of FABP4 mRNA	22956630
C038091	butylparaben	butylparaben promotes the reaction [Dexamethasone results in increased expression of FABP4 mRNA]	22956630
C038091	butylparaben	butylparaben results in increased expression of FABP4 mRNA	22956630\|2415596
C038091	butylparaben	NR3C1 protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA]	28527915
C038091	butylparaben	PPARG mutant form inhibits the reaction [butylparaben results in increased expression of FABP4 mRNA]	22956630
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA]	28527915
D002104	Cadmium	Cadmium results in increased expression of FABP4 mRNA	17327700
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of FABP4 mRNA	17327700\|2599309
D002110	Caffeine	Caffeine results in decreased expression of FABP4 mRNA	23727198
D002110	Caffeine	Caffeine results in decreased expression of FABP4 mRNA	23727198
D002211	Capsaicin	Capsaicin results in decreased expression of FABP4 mRNA	18533110
D002211	Capsaicin	Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of FABP4 mRNA]	20359164
D002211	Capsaicin	Capsaicin inhibits the reaction [Dietary Fats results in increased expression of FABP4 protein]	20359164
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of FABP4 mRNA	17484886\|2733941
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in increased expression of FABP4 mRNA	16239168
D002273	Carcinogens	Carcinogens results in decreased expression of FABP4 mRNA	16316942
D048271	Chitosan	Chitosan inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D048271	Chitosan	[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D002713	Chlorine	[Ozone co-treated with Chlorine] results in increased expression of FABP4 mRNA	18636392
C004656	chloroacetaldehyde	chloroacetaldehyde affects the expression of FABP4 mRNA	25596134
D002794	Choline	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA	20938992
C039671	ciglitazone	ciglitazone results in increased expression of FABP4 mRNA	16847310
D002922	Ciguatoxins	Ciguatoxins affects the expression of FABP4 mRNA	18353800
C019304	ciprofibrate	ciprofibrate results in increased expression of FABP4 mRNA	12771043
D002994	Clofibrate	[Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA	9543393
D002994	Clofibrate	Clofibrate results in decreased expression of FABP4 mRNA	21392566
D002994	Clofibrate	[Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA	8536680
D002994	Clofibrate	[Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA	8536680
D002995	Clofibric Acid	Clofibric Acid affects the expression of FABP4 mRNA	17602206
C007095	cobaltiprotoporphyrin	cobaltiprotoporphyrin affects the expression of FABP4 protein	23497794
C018021	cobaltous chloride	cobaltous chloride results in decreased expression of FABP4 mRNA	12032628
D019327	Copper Sulfate	Copper Sulfate results in decreased expression of FABP4 mRNA	12860252
D003348	Cortisone	"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of FABP4 mRNA]"	21315688
D003348	Cortisone	Cortisone results in increased expression of FABP4 mRNA	21315688
C041246	cucurbitacin B	cucurbitacin B results in decreased expression of FABP4 mRNA	24316209
C038106	cucurbitacin I	cucurbitacin I results in decreased expression of FABP4 mRNA	24316209
C500528	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester results in increased expression of FABP4 mRNA	27659731
C009160	cyclonite	cyclonite results in decreased expression of FABP4 mRNA	25559034
D016572	Cyclosporine	Cyclosporine results in decreased expression of FABP4 mRNA	20106945\|2798913
D016572	Cyclosporine	Cyclosporine results in decreased expression of FABP4 mRNA	19770486
D003634	DDT	DDT results in increased expression of FABP4 mRNA	25014179
D003676	Deferoxamine	Deferoxamine results in decreased expression of FABP4 mRNA	12032628
D015230	Prostaglandin D2	Prostaglandin D2 results in increased expression of FABP4 mRNA	9543393
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	26200599
D003907	Dexamethasone	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	25932594
D003907	Dexamethasone	Dexamethasone results in increased expression of FABP4 mRNA	19853017\|2441882
D003907	Dexamethasone	Dexamethasone results in increased expression of FABP4 protein	24418828\|2700384
D003907	Dexamethasone	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]	26200599
D003907	Dexamethasone	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP4 mRNA	28628672
D003907	Dexamethasone	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FABP4 protein]	24418828\|2700384
D003907	Dexamethasone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
D003907	Dexamethasone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	20206132
D003907	Dexamethasone	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D003907	Dexamethasone	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D003907	Dexamethasone	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	20206132
D003907	Dexamethasone	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23428407
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein	25559859
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	24848799
D003907	Dexamethasone	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D003907	Dexamethasone	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA	25062436
D003907	Dexamethasone	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA	25062436
D003907	Dexamethasone	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D003907	Dexamethasone	bisphenol A promotes the reaction [Dexamethasone results in increased expression of FABP4 protein]	25068083
D003907	Dexamethasone	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
D003907	Dexamethasone	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
D003907	Dexamethasone	butylparaben promotes the reaction [Dexamethasone results in increased expression of FABP4 mRNA]	22956630
D003907	Dexamethasone	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
D003907	Dexamethasone	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607\|2803146
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607\|2828564
D003907	Dexamethasone	[Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	9543393
D003907	Dexamethasone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA	16054899
D003907	Dexamethasone	Dexamethasone results in increased expression of FABP4 mRNA	22956630\|2506808
D003907	Dexamethasone	Dexamethasone results in increased expression of FABP4 protein	25068083\|2601813
D003907	Dexamethasone	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D003907	Dexamethasone	GW0072 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D003907	Dexamethasone	GW 2331 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA	26972250
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 protein	27163856
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA	11812925
D003907	Dexamethasone	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
D003907	Dexamethasone	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]]	26972250
D003907	Dexamethasone	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of FABP4 mRNA	29288687
D003907	Dexamethasone	pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D003907	Dexamethasone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of FABP4 mRNA	29288687
D003907	Dexamethasone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
D003907	Dexamethasone	rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D003907	Dexamethasone	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
D003907	Dexamethasone	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein]	25559859
D003907	Dexamethasone	sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	11812925
D003907	Dexamethasone	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
D003907	Dexamethasone	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
D003907	Dexamethasone	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
D003907	Dexamethasone	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
D003907	Dexamethasone	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D003907	Dexamethasone	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D003907	Dexamethasone	TGFB1 inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	9543393
D003907	Dexamethasone	TNF inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	9543393
D003907	Dexamethasone	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D003907	Dexamethasone	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
D003907	Dexamethasone	[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of FABP4 mRNA	21350315
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA	27602593
D003907	Dexamethasone	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
D003907	Dexamethasone	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
D003907	Dexamethasone	[Dexamethasone results in increased activity of NR3C1 protein] which results in increased expression of FABP4 mRNA	26018136
D016264	Dextran Sulfate	[Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA	26271895
C438269	diazepinylbenzoic acid	diazepinylbenzoic acid inhibits the reaction [tributyltin results in increased expression of FABP4 mRNA]	25932594
D002945	Cisplatin	Cisplatin results in decreased expression of FABP4 mRNA	22023808
D003633	Dichlorodiphenyl Dichloroethylene	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]	26200599
D004041	Dietary Fats	[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 protein	28611668
D004041	Dietary Fats	[Dietary Fats co-treated with rosiglitazone] results in increased expression of FABP4 mRNA	18276752
D004041	Dietary Fats	Dietary Fats results in decreased expression of FABP4 mRNA	18042831
D004041	Dietary Fats	Dietary Fats results in increased expression of FABP4 mRNA	16357043\|2219828
D004041	Dietary Fats	Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	26408789
D004041	Dietary Fats	[hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of FABP4 mRNA	24398136
D004041	Dietary Fats	[INT 131 co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
D004041	Dietary Fats	INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
D004041	Dietary Fats	naringin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	22198281
D004041	Dietary Fats	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	22967722
D004041	Dietary Fats	[rosiglitazone co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
D004041	Dietary Fats	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
D004041	Dietary Fats	Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of FABP4 mRNA]	20359164
D004041	Dietary Fats	Capsaicin inhibits the reaction [Dietary Fats results in increased expression of FABP4 protein]	20359164
D004041	Dietary Fats	Chitosan inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D004041	Dietary Fats	Dietary Fats results in increased expression of FABP4 mRNA	20359164\|2898736
D004041	Dietary Fats	Dietary Fats results in increased expression of FABP4 protein	20359164
D004041	Dietary Fats	[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D004041	Dietary Fats	Fish Oils inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D004041	Dietary Fats	Dietary Fats results in increased expression of FABP4 mRNA	21852083
D004041	Dietary Fats	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	21852083
D004041	Dietary Fats	resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	21852083
D000073417	Dietary Sugars	[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 protein	28611668
D000073417	Dietary Sugars	[INT 131 co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
D000073417	Dietary Sugars	INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
D000073417	Dietary Sugars	[rosiglitazone co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
D000073417	Dietary Sugars	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of FABP4 mRNA	19245819\|1985064
D004051	Diethylhexyl Phthalate	PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of FABP4 mRNA]	19850644
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of FABP4 mRNA	12771043\|2453584
D004052	Diethylnitrosamine	[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of FABP4 mRNA	18164116
D004052	Diethylnitrosamine	Diethylnitrosamine results in increased expression of FABP4 mRNA	19638242
D004054	Diethylstilbestrol	Diethylstilbestrol results in increased expression of FABP4 mRNA	22710028
C544754	dihydroresveratrol	dihydroresveratrol results in decreased expression of FABP4	21852083
D002117	Calcitriol	Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA]	9564879
D002117	Calcitriol	"Calcitriol promotes the reaction [pregna-4,17-diene-3,16-dione results in decreased expression of FABP4 protein]"	17959142
D002117	Calcitriol	Calcitriol results in decreased expression of FABP4 mRNA	16368784\|1681352
D002117	Calcitriol	Calcitriol results in decreased expression of FABP4 protein	17959142
D002117	Calcitriol	"pregna-4,17-diene-3,16-dione promotes the reaction [Calcitriol results in decreased expression of FABP4 protein]"	17959142
D015127	9,10-Dimethyl-1,2-benzanthracene	"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of FABP4 mRNA"	22485181
D019813	1,2-Dimethylhydrazine	"[APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of FABP4 mRNA"	27840820
D004143	Dioctyl Sulfosuccinic Acid	Dioctyl Sulfosuccinic Acid results in increased expression of FABP4 mRNA	26135921
D004144	Diosgenin	Diosgenin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	26408789
D004144	Diosgenin	Diosgenin results in decreased expression of FABP4 mRNA	26408789
D004144	Diosgenin	fulvestrant inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
D004144	Diosgenin	PPARG protein inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
D004144	Diosgenin	rosiglitazone inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
C550453	dioxinodehydroeckol	dioxinodehydroeckol results in decreased expression of FABP4 mRNA	20385110
C076126	disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	"disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of FABP4 mRNA"	20184727
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in decreased expression of FABP4 mRNA	21569430
D004317	Doxorubicin	Doxorubicin results in increased expression of FABP4 mRNA	22016648
D004785	Environmental Pollutants	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
D004967	Estrogens	Estrogens results in increased expression of FABP4 mRNA	25014179
D000431	Ethanol	Ethanol results in decreased expression of FABP4 mRNA	15513904\|2217391
D000431	Ethanol	rosiglitazone inhibits the reaction [Ethanol results in decreased expression of FABP4 mRNA]	22173916
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of FABP4 mRNA	17942748
C024565	ethylene dichloride	ethylene dichloride results in decreased expression of FABP4 mRNA	28189721
C012313	ethyl-p-hydroxybenzoate	ethyl-p-hydroxybenzoate results in increased expression of FABP4 mRNA	22956630
C018063	ethyl protocatechuate	ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of FABP4 mRNA]	24338020
D011345	Fenofibrate	Fenofibrate results in increased expression of FABP4 mRNA	12759900\|2557248
D011345	Fenofibrate	Fenofibrate results in increased expression of FABP4 mRNA	11798191
C082360	fipronil	fipronil results in increased expression of FABP4 mRNA	27103584
C000591741	Firemaster 550	Firemaster 550 results in increased expression of FABP4 protein	28934090
C000591741	Firemaster 550	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with Firemaster 550] results in increased expression of FABP4 mRNA	25062436
D005395	Fish Oils	[Fish Oils co-treated with Chitosan] inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D005395	Fish Oils	Fish Oils inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	28987369
D005411	Flame Retardants	Flame Retardants results in increased expression of FABP4 protein	28934090
C006326	fluprostenol	fluprostenol inhibits the reaction [Niacin results in increased expression of FABP4 mRNA]	21236357
D005492	Folic Acid	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA	20938992
D002955	Leucovorin	Leucovorin inhibits the reaction [Methotrexate results in increased expression of FABP4 protein]	25187349
D005632	Fructose	[Fructose co-treated with bisphenol A] results in increased expression of FABP4 protein	26930160
C070081	fulvestrant	fulvestrant inhibits the reaction [bis(4-hydroxyphenyl)sulfone results in increased expression of FABP4 protein]	27003841
C070081	fulvestrant	fulvestrant inhibits the reaction [bisphenol A results in increased expression of FABP4 protein]	24418828
C070081	fulvestrant	fulvestrant inhibits the reaction [bisphenol A glucuronide results in increased expression of FABP4 protein]	26018136
C070081	fulvestrant	fulvestrant inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
C039281	furan	furan results in increased expression of FABP4 mRNA	26194646
C049864	ginsenoside Re	ginsenoside Re results in increased expression of FABP4 mRNA	23545455
D005897	Glafenine	Glafenine results in increased expression of FABP4 mRNA	24136188
D005944	Glucosamine	Glucosamine results in increased expression of FABP4 mRNA	15694357
D005944	Glucosamine	Glucosamine results in increased expression of FABP4 mRNA	15694357
C046905	glucosamine 6-O-sulfate	glucosamine 6-O-sulfate results in decreased expression of FABP4 mRNA	19520133
C001293	glucosamine 6-phosphate	glucosamine 6-phosphate results in decreased expression of FABP4 mRNA	19427183
D005947	Glucose	[Glucose deficiency co-treated with ALB protein] results in decreased expression of FABP4 mRNA	8536680
D005947	Glucose	[Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA	8536680
D005947	Glucose	[Glucose deficiency co-treated with Clofibrate] results in increased expression of FABP4 mRNA	8536680
D005947	Glucose	[Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA	8536680
C424943	glutamyl-Se-methylselenocysteine	glutamyl-Se-methylselenocysteine results in decreased expression of FABP4 mRNA	11306469
C577920	GSK126	GSK126 results in decreased expression of FABP4 mRNA	26424790
C119543	GW0072	GW0072 results in increased expression of FABP4 mRNA	15273253
C119543	GW0072	GW0072 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
C105715	GW 2331	GW 2331 results in increased expression of FABP4 mRNA	15273253
C105715	GW 2331	GW 2331 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
C449302	GW 6471	GW 6471 inhibits the reaction [PPARA protein promotes the reaction [GW 7647 results in increased expression of FABP4 mRNA]]	21324916
C449302	GW 6471	GW 6471 results in decreased expression of FABP4 mRNA	21324916
C453899	GW 7647	GW 6471 inhibits the reaction [PPARA protein promotes the reaction [GW 7647 results in increased expression of FABP4 mRNA]]	21324916
C453899	GW 7647	GW 7647 promotes the reaction [PPARA protein binds to FABP4 promoter]	21324916
C453899	GW 7647	GW 7647 results in increased expression of FABP4 mRNA	21324916
C453899	GW 7647	PPARA protein promotes the reaction [GW 7647 results in increased expression of FABP4 mRNA]	21324916
C401311	GW 7845	GW 7845 results in increased expression of FABP4 mRNA	20519739
D055768	Halogenated Diphenyl Ethers	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of FABP4 mRNA"	27602593
D006247	Harmine	[phenylamil co-treated with Harmine] results in increased expression of FABP4 mRNA	20519739
C013015	hesperetin	hesperetin results in decreased expression of FABP4 mRNA	25345581
C089796	hexabromocyclododecane	[hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of FABP4 mRNA	24398136
C000625835	HFPO2 compound	HFPO2 compound results in increased expression of FABP4 mRNA	27553808
C000625836	HFPO4 compound	HFPO4 compound results in increased expression of FABP4 mRNA	27553808
D017313	Fenretinide	Fenretinide results in decreased expression of FABP4 mRNA	28973697
D006834	Hydrazines	Hydrazines results in decreased expression of FABP4 mRNA	21647536
D006834	Hydrazines	Hydrazines results in decreased expression of FABP4 protein	21647536
D006843	Hydrocarbons, Chlorinated	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of FABP4 mRNA"	27602593
D007052	Ibuprofen	Ibuprofen results in decreased expression of FABP4 mRNA	17070997
D007052	Ibuprofen	Ibuprofen results in increased expression of FABP4 mRNA	25596134
C041508	indeno(1,2,3-cd)pyrene	"indeno(1,2,3-cd)pyrene results in decreased expression of FABP4 mRNA"	26377693
C016517	indole-3-carbinol	indole-3-carbinol affects the expression of FABP4 mRNA	21396975
D007213	Indomethacin	Indomethacin results in increased expression of FABP4 mRNA	15273253
D007213	Indomethacin	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP4 mRNA	28628672
D007213	Indomethacin	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
D007213	Indomethacin	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D007213	Indomethacin	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D007213	Indomethacin	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
C541917	INT 131	[INT 131 co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
C541917	INT 131	INT 131 inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
C541917	INT 131	INT 131 results in increased expression of FABP4 mRNA	19452630\|2861166
D015759	Ionomycin	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FABP4 mRNA	25613284
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	26200599
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of FABP4 mRNA	27003841
D015056	1-Methyl-3-isobutylxanthine	1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA	22645054
D015056	1-Methyl-3-isobutylxanthine	aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA]	22645054
D015056	1-Methyl-3-isobutylxanthine	Dichlorodiphenyl Dichloroethylene promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA]	26200599
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of FABP4 mRNA	28628672
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	20206132
D015056	1-Methyl-3-isobutylxanthine	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D015056	1-Methyl-3-isobutylxanthine	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
D015056	1-Methyl-3-isobutylxanthine	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	20206132
D015056	1-Methyl-3-isobutylxanthine	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of FABP4 mRNA	26820058
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23428407
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein	25559859
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA	24848799
D015056	1-Methyl-3-isobutylxanthine	1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA	9564879
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
D015056	1-Methyl-3-isobutylxanthine	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
D015056	1-Methyl-3-isobutylxanthine	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D015056	1-Methyl-3-isobutylxanthine	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
D015056	1-Methyl-3-isobutylxanthine	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
D015056	1-Methyl-3-isobutylxanthine	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
D015056	1-Methyl-3-isobutylxanthine	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
D015056	1-Methyl-3-isobutylxanthine	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D015056	1-Methyl-3-isobutylxanthine	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
D015056	1-Methyl-3-isobutylxanthine	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
D015056	1-Methyl-3-isobutylxanthine	Calcitriol inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of FABP4 mRNA]	9564879
D015056	1-Methyl-3-isobutylxanthine	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
D015056	1-Methyl-3-isobutylxanthine	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607\|2803146
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607\|2828564
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA	16054899
D015056	1-Methyl-3-isobutylxanthine	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D015056	1-Methyl-3-isobutylxanthine	GW0072 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D015056	1-Methyl-3-isobutylxanthine	GW 2331 promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D015056	1-Methyl-3-isobutylxanthine	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA	26972250
D015056	1-Methyl-3-isobutylxanthine	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 protein	27163856
D015056	1-Methyl-3-isobutylxanthine	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
D015056	1-Methyl-3-isobutylxanthine	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]]	26972250
D015056	1-Methyl-3-isobutylxanthine	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of FABP4 mRNA	29288687
D015056	1-Methyl-3-isobutylxanthine	pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of FABP4 mRNA	29288687
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
D015056	1-Methyl-3-isobutylxanthine	rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
D015056	1-Methyl-3-isobutylxanthine	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
D015056	1-Methyl-3-isobutylxanthine	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein]	25559859
D015056	1-Methyl-3-isobutylxanthine	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
D015056	1-Methyl-3-isobutylxanthine	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
D015056	1-Methyl-3-isobutylxanthine	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
D015056	1-Methyl-3-isobutylxanthine	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
D015056	1-Methyl-3-isobutylxanthine	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D015056	1-Methyl-3-isobutylxanthine	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D015056	1-Methyl-3-isobutylxanthine	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
D015056	1-Methyl-3-isobutylxanthine	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
D015056	1-Methyl-3-isobutylxanthine	[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of FABP4 mRNA	21350315
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA	27602593
D015056	1-Methyl-3-isobutylxanthine	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
D015056	1-Methyl-3-isobutylxanthine	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
C040920	isoliquiritigenin	isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of FABP4 protein]	27117918
C027681	isonicotinamide	isonicotinamide results in decreased expression of FABP4 mRNA	16813520
C027681	isonicotinamide	isonicotinamide results in increased expression of FABP4 mRNA	16813520
C098607	JP8 aviation fuel	JP8 aviation fuel results in decreased expression of FABP4 mRNA	15618438
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]]	26972250
C468270	Kangen-karyu	Kangen-karyu results in decreased expression of FABP4 protein	25031044
D007854	Lead	Lead results in increased expression of FABP4	23086611
D007854	Lead	Lead results in increased expression of FABP4 mRNA	23086611
C008261	lead acetate	lead acetate results in decreased expression of FABP4 mRNA	22609695
C432503	licarin A	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of FABP4 mRNA	29288687
D008070	Lipopolysaccharides	Lipopolysaccharides results in decreased expression of FABP4 mRNA	16847310
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of FABP4 mRNA	15705927\|2733941
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of FABP4 protein	15705927
D058185	Magnetite Nanoparticles	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA	26378955
D058185	Magnetite Nanoparticles	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA	21641980
C586321	mansonone G	mansonone G analog results in decreased expression of FABP4 mRNA	28625492
C586321	mansonone G	mansonone G results in decreased expression of FABP4 mRNA	28625492
D008550	Melatonin	Melatonin results in decreased expression of FABP4 mRNA	20738756
C000600817	mercaptosteroid 6	mercaptosteroid 6 results in increased expression of FABP4 mRNA	25851902
D008715	Methionine	[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FABP4 mRNA	20938992
D008727	Methotrexate	Leucovorin inhibits the reaction [Methotrexate results in increased expression of FABP4 protein]	25187349
D008727	Methotrexate	Methotrexate results in increased expression of FABP4 mRNA	25187349
D008748	Methylcholanthrene	"[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FABP4 mRNA"	25926378
D008748	Methylcholanthrene	Methylcholanthrene results in decreased expression of FABP4 mRNA	25926378
D015735	Mifepristone	Mifepristone inhibits the reaction [Dexamethasone results in increased expression of FABP4 protein]	24418828\|2700384
D015735	Mifepristone	Mifepristone inhibits the reaction [bisphenol A results in increased expression of FABP4 mRNA]	27145005
D015735	Mifepristone	Mifepristone results in increased expression of FABP4 protein	26018136
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate analog results in increased expression of FABP4 mRNA	25777084
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 mRNA	25543134\|2577708
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 protein	27384973
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	27602593
C500085	muraglitazar	muraglitazar results in increased expression of FABP4 mRNA	21515302
C510788	N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine	"N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine results in increased expression of FABP4 mRNA"	25487280
D037742	Nanotubes, Carbon	"[Methylcholanthrene co-treated with Nanotubes, Carbon] results in decreased expression of FABP4 mRNA"	25926378
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of FABP4 mRNA"	25620056
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in increased expression of FABP4 mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of FABP4 mRNA"	25554681\|2562005
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of FABP4 mRNA"	19836432
C005274	naringin	naringin inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	22198281
C017096	n-butoxyethanol	n-butoxyethanol results in increased expression of FABP4 mRNA	19812364
D009525	Niacin	fluprostenol inhibits the reaction [Niacin results in increased expression of FABP4 mRNA]	21236357
D009525	Niacin	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 mRNA	21236357
D009525	Niacin	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 protein	21236357
C028007	nickel monoxide	nickel monoxide results in increased expression of FABP4 mRNA	19167457
C025589	ochratoxin A	ochratoxin A results in decreased expression of FABP4	20590410
D019787	Linoleic Acid	Linoleic Acid analog affects the localization of FABP4 protein	27939595
D019301	Oleic Acid	Oleic Acid results in increased expression of FABP4 mRNA	26739624
D019301	Oleic Acid	[Glucose deficiency co-treated with Clofibrate co-treated with Oleic Acid] results in increased expression of FABP4 mRNA	8536680
D019301	Oleic Acid	[Glucose deficiency co-treated with Oleic Acid] results in increased expression of FABP4 mRNA	8536680
D019301	Oleic Acid	Oleic Acid analog affects the localization of FABP4 protein	27939595
C108709	oleoyl-estrone	oleoyl-estrone results in decreased expression of FABP4 mRNA	17725831\|1932603
C507134	ON 01910	ON 01910 affects the expression of FABP4 mRNA	22351695
C046627	osthol	osthol results in increased expression of FABP4 mRNA	19682441
C030110	oxaliplatin	[oxaliplatin co-treated with Topotecan] results in increased expression of FABP4 mRNA	25729387
C030110	oxaliplatin	oxaliplatin results in increased expression of FABP4 mRNA	25729387
D010100	Oxygen	Oxygen deficiency results in decreased expression of FABP4 mRNA	12032628
D010100	Oxygen	Oxygen deficiency results in increased expression of FABP4 mRNA	20880076
D010126	Ozone	[Ozone co-treated with Chlorine] results in increased expression of FABP4 mRNA	18636392
C053370	paclobutrazol	paclobutrazol results in increased expression of FABP4 mRNA	23202249
D000073878	Palm Oil	Palm Oil results in decreased expression of FABP4 mRNA	18042831
C016030	pantogab	pantogab results in increased expression of FABP4 mRNA	17379144
C471071	perfluorohexanesulfonic acid	perfluorohexanesulfonic acid results in increased expression of FABP4 mRNA	21705711
C101814	perfluoro-n-undecanoic acid	perfluoro-n-undecanoic acid results in increased expression of FABP4 mRNA	23602845
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of FABP4 mRNA	21705711\|2654859
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of FABP4 mRNA	22237054
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of FABP4 mRNA	18467677
C023036	perfluorooctanoic acid	PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of FABP4 mRNA]	18467677
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of FABP4 mRNA	19162173
D026023	Permethrin	Permethrin results in increased expression of FABP4 mRNA	24911977
D010575	Pesticides	Pesticides results in increased methylation of FABP4 gene	28396702
D010615	Phenacetin	Phenacetin results in increased expression of FABP4 mRNA	17698508
D010634	Phenobarbital	Phenobarbital results in increased expression of FABP4 mRNA	19084549
D010634	Phenobarbital	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FABP4 mRNA]	19482888
D010634	Phenobarbital	Phenobarbital results in increased expression of FABP4 mRNA	19482888
C047088	phenylamil	[phenylamil co-treated with Harmine] results in increased expression of FABP4 mRNA	20519739
C047088	phenylamil	phenylamil results in increased expression of FABP4 mRNA	20519739
C047088	phenylamil	PPARG protein promotes the reaction [phenylamil results in increased expression of FABP4 mRNA]	20519739
D010656	Phenylephrine	Phenylephrine results in decreased expression of FABP4 mRNA	18158353
C030299	phenylhydrazine	phenylhydrazine results in increased expression of FABP4 mRNA	17698508
C060836	pioglitazone	[pioglitazone co-treated with Tretinoin] results in increased expression of FABP4 mRNA	16573735
C060836	pioglitazone	pioglitazone results in increased expression of FABP4 mRNA	15273253\|1657373
C060836	pioglitazone	pioglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
C060836	pioglitazone	pioglitazone results in increased expression of FABP4 mRNA	12927809\|1729000
C006253	pirinixic acid	[pirinixic acid co-treated with PPARA] results in increased expression of FABP4 mRNA	20813756
C006253	pirinixic acid	pirinixic acid results in increased expression of FABP4 mRNA	11798191\|1635704
C006253	pirinixic acid	PPARA protein promotes the reaction [pirinixic acid results in increased expression of FABP4 mRNA]	18467677\|2005976
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	22967722
D010936	Plant Extracts	Plant Extracts results in decreased expression of FABP4 protein	23810795\|2684561
D010936	Plant Extracts	Plant Extracts results in increased expression of FABP4 mRNA	21392566\|2368475
D010936	Plant Extracts	Plant Extracts results in decreased expression of FABP4 mRNA	23306787
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	21852083
D028321	Plant Preparations	Plant Preparations results in increased expression of FABP4 mRNA	26945725
D011078	Polychlorinated Biphenyls	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of FABP4 mRNA"	27602593
D011070	Poly I-C	Poly I-C results in increased expression of FABP4 mRNA	15705927
D011192	Potassium Dichromate	Potassium Dichromate results in decreased expression of FABP4 mRNA	23608068
C023617	pregna-4,17-diene-3,16-dione	"Calcitriol promotes the reaction [pregna-4,17-diene-3,16-dione results in decreased expression of FABP4 protein]"	17959142
C023617	pregna-4,17-diene-3,16-dione	"pregna-4,17-diene-3,16-dione promotes the reaction [Calcitriol results in decreased expression of FABP4 protein]"	17959142
C023617	pregna-4,17-diene-3,16-dione	"pregna-4,17-diene-3,16-dione results in decreased expression of FABP4 protein"	17959142
D011374	Progesterone	Progesterone results in increased expression of FABP4 mRNA	15713686
D011374	Progesterone	Progesterone results in increased expression of FABP4 mRNA	21770760
C006068	propylparaben	propylparaben results in increased expression of FABP4 mRNA	22956630\|2415596
D015237	Dinoprost	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 mRNA	21236357
D015237	Dinoprost	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of FABP4 protein	21236357
C024070	pycnogenols	pycnogenols results in decreased expression of FABP4 mRNA	21796705
D011791	Quartz	Quartz results in increased expression of FABP4 mRNA	19836432
D020849	Raloxifene Hydrochloride	Raloxifene Hydrochloride results in increased expression of FABP4 mRNA	16643890
C059514	resveratrol	resveratrol affects the secretion of FABP4 protein	24802182
C059514	resveratrol	resveratrol results in decreased expression of FABP4	21852083
C059514	resveratrol	resveratrol results in decreased expression of FABP4 mRNA	16813520\|1855585
C059514	resveratrol	resveratrol results in decreased expression of FABP4 protein	23525482\|2576141
C059514	resveratrol	splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 mRNA]	23525482
C059514	resveratrol	splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 protein]	23525482
C059514	resveratrol	resveratrol inhibits the reaction [Dietary Fats results in increased expression of FABP4 mRNA]	21852083
D015474	Isotretinoin	Isotretinoin results in increased expression of FABP4 mRNA	19212007
C084904	Ro 41-5253	Ro 41-5253 results in increased expression of FABP4 mRNA	17290005
C116926	rofecoxib	rofecoxib results in decreased expression of FABP4 mRNA	17070997
C089730	rosiglitazone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
C089730	rosiglitazone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	20206132
C089730	rosiglitazone	rosiglitazone results in increased expression of FABP4	17993761
C089730	rosiglitazone	rosiglitazone results in increased expression of FABP4 mRNA	15273253\|1561907
C089730	rosiglitazone	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
C089730	rosiglitazone	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	20206132
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	27273607
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	27273607
C089730	rosiglitazone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA	16054899
C089730	rosiglitazone	[Dietary Fats co-treated with rosiglitazone] results in increased expression of FABP4 mRNA	18276752
C089730	rosiglitazone	ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of FABP4 mRNA]	24338020
C089730	rosiglitazone	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]]	26972250
C089730	rosiglitazone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in decreased expression of FABP4 mRNA	29288687
C089730	rosiglitazone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
C089730	rosiglitazone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA	27273607
C089730	rosiglitazone	[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein	27273607
C089730	rosiglitazone	[rosiglitazone co-treated with Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA	28611668
C089730	rosiglitazone	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Dietary Sugars] results in increased expression of FABP4 mRNA]	28611668
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Ethanol results in decreased expression of FABP4 mRNA]	22173916
C089730	rosiglitazone	rosiglitazone promotes the reaction [[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	15273253
C089730	rosiglitazone	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	26972250
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]	10871190
C089730	rosiglitazone	rosiglitazone results in decreased expression of FABP4 mRNA	21392566
C089730	rosiglitazone	rosiglitazone results in decreased expression of FABP4 protein	28329833
C089730	rosiglitazone	rosiglitazone results in increased expression of FABP4 mRNA	10871190\|1202120
C089730	rosiglitazone	rosiglitazone results in increased expression of FABP4 protein	21347706\|2162294
C089730	rosiglitazone	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
C089730	rosiglitazone	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
C089730	rosiglitazone	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
C089730	rosiglitazone	Tungsten promotes the reaction [rosiglitazone results in increased expression of FABP4 mRNA]	26865663
C089730	rosiglitazone	rosiglitazone results in increased expression of FABP4 mRNA	10799317\|2117241
D012402	Rotenone	Rotenone results in increased expression of FABP4 mRNA	22016648
C040115	shogaol	2-chloro-5-nitrobenzanilide inhibits the reaction [shogaol results in increased expression of FABP4 mRNA]	18577375
C040115	shogaol	shogaol results in increased expression of FABP4 mRNA	18577375
D000068677	Sildenafil Citrate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of FABP4 protein]"	20471953
D000068677	Sildenafil Citrate	Sildenafil Citrate results in increased expression of FABP4 mRNA	20471953
D000068677	Sildenafil Citrate	Sildenafil Citrate results in increased expression of FABP4 protein	20471953
D012822	Silicon Dioxide	Silicon Dioxide analog affects the expression of FABP4 mRNA	23806026
D012822	Silicon Dioxide	Silicon Dioxide results in increased expression of FABP4 mRNA	19073995
D012822	Silicon Dioxide	Silicon Dioxide results in increased expression of FABP4 mRNA	22431001
C440975	silybin	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein]	25559859
C017947	sodium arsenite	sodium arsenite results in decreased expression of FABP4 mRNA	20371982
C017947	sodium arsenite	sodium arsenite results in increased expression of FABP4 mRNA	28595984
C017947	sodium arsenite	sodium arsenite affects the expression of FABP4 mRNA	28206643
C017947	sodium arsenite	sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of FABP4 mRNA]	11812925
C017947	sodium arsenite	sodium arsenite results in decreased expression of FABP4 mRNA	21512104\|2270054
C016104	sodium bichromate	sodium bichromate results in increased expression of FABP4 mRNA	25993096
D012969	Sodium Fluoride	Sodium Fluoride results in decreased expression of FABP4 mRNA	27862939
C538809	sodium pentaborate	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]]	28285642
C538809	sodium pentaborate	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 mRNA]	28285642
C538809	sodium pentaborate	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein]	28285642
C444426	splitomicin	splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 mRNA]	23525482
C444426	splitomicin	splitomicin promotes the reaction [resveratrol results in decreased expression of FABP4 protein]	23525482
D004113	Succimer	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA	26378955
D004113	Succimer	[Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA	21641980
D012460	Sulfasalazine	Sulfasalazine results in increased expression of FABP4 mRNA	22016648
C025462	sulindac sulfide	2-chloro-5-nitrobenzanilide inhibits the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]	17602619
C025462	sulindac sulfide	PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]	18665581
C025462	sulindac sulfide	sulindac sulfide analog results in increased expression of FABP4 protein	17602619\|1866558
C458508	T 0070907	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
C458508	T 0070907	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
C458508	T 0070907	T 0070907 inhibits the reaction [[rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
C458508	T 0070907	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
D014284	Triiodothyronine	Triiodothyronine results in increased expression of FABP4 mRNA	15953391
D013629	Tamoxifen	Tamoxifen results in decreased expression of FABP4 protein	27358406
C031655	tauroursodeoxycholic acid	tauroursodeoxycholic acid results in decreased expression of FABP4 mRNA	24312631
C501413	tesaglitazar	tesaglitazar results in increased expression of FABP4 mRNA	21515302
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in decreased expression of FABP4 protein	28329833
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of FABP4 mRNA	25777084\|2586318
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of FABP4 protein	25863188
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin affects the expression of FABP4 mRNA	22574217
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of FABP4 mRNA	20106945\|2226271
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of FABP4 mRNA	16054899
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	16054899
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of FABP4 mRNA	15591033\|1605489
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of FABP4 mRNA	16960034\|1794274
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of FABP4 mRNA	16960034
D013752	Tetracycline	Tetracycline results in decreased expression of FABP4 mRNA	16917069
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FABP4 mRNA	25613284
D013853	Thioacetamide	Thioacetamide results in increased expression of FABP4 mRNA	23411599
C009495	titanium dioxide	titanium dioxide affects the expression of FABP4 mRNA	23557971
D019772	Topotecan	[oxaliplatin co-treated with Topotecan] results in increased expression of FABP4 mRNA	25729387
D019772	Topotecan	Topotecan results in increased expression of FABP4 mRNA	25729387
D014212	Tretinoin	"[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with Tretinoin] results in increased expression of FABP4 mRNA"	16573735
D014212	Tretinoin	[pioglitazone co-treated with Tretinoin] results in increased expression of FABP4 mRNA	16573735
D014212	Tretinoin	Tretinoin results in increased expression of FABP4 mRNA	16054129
C032910	triadimefon	triadimefon results in decreased expression of FABP4 mRNA	26705709
C011559	tributyltin	tributyltin results in increased expression of FABP4 mRNA	28011154
C011559	tributyltin	diazepinylbenzoic acid inhibits the reaction [tributyltin results in increased expression of FABP4 mRNA]	25932594
C011559	tributyltin	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]	22197818
C011559	tributyltin	tributyltin results in increased expression of FABP4 mRNA	15993011\|2162294
C011559	tributyltin	tributyltin results in increased expression of FABP4 protein	21622945
C012589	trichostatin A	trichostatin A results in increased expression of FABP4 mRNA	26705709
D014260	Triclosan	Triclosan results in decreased expression of FABP4 mRNA	22726953
C053549	triflumizol	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA]	23086663
C053549	triflumizol	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of FABP4 mRNA	23086663
C053549	triflumizol	T 0070907 inhibits the reaction [[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA]	23086663
C053549	triflumizol	[triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 mRNA	23086663
C053549	triflumizol	triflumizol results in increased expression of FABP4 mRNA	23086663
C005445	triphenyl phosphate	triphenyl phosphate results in increased expression of FABP4 mRNA	28934090
C005445	triphenyl phosphate	triphenyl phosphate results in increased expression of FABP4 protein	28934090
C005445	triphenyl phosphate	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS1 protein co-treated with triphenyl phosphate] results in increased expression of FABP4 mRNA	25062436
C030665	triphenyltin	triphenyltin results in increased expression of FABP4 mRNA	25777084
C050414	tripterine	tripterine affects the expression of FABP4 mRNA	27085773
C057693	troglitazone	[1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of FABP4 mRNA	27003841
C057693	troglitazone	troglitazone results in increased expression of FABP4 mRNA	10097144\|1116257
C057693	troglitazone	troglitazone results in increased expression of FABP4 protein	9709955
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]	10871190
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA	11089532
C057693	troglitazone	troglitazone results in increased expression of FABP4 mRNA	10871190\|1108953
C057693	troglitazone	troglitazone results in increased expression of FABP4 mRNA	21515302\|2187775
D014414	Tungsten	Tungsten promotes the reaction [rosiglitazone results in increased expression of FABP4 mRNA]	26865663
D014414	Tungsten	Tungsten results in increased expression of FABP4 mRNA	26865663
D014415	Tunicamycin	Tunicamycin results in increased expression of FABP4 mRNA	17127020
D014580	Ursodeoxycholic Acid	Ursodeoxycholic Acid results in decreased expression of FABP4 mRNA	24312631
D014635	Valproic Acid	Valproic Acid results in decreased methylation of FABP4 gene	29154799
D014635	Valproic Acid	Valproic Acid results in increased expression of FABP4 mRNA	23179753
D014635	Valproic Acid	Valproic Acid results in increased expression of FABP4 mRNA	24489787
D000068756	Valsartan	Valsartan results in decreased expression of FABP4 mRNA	22768174
C066075	vanadium pentoxide	vanadium pentoxide results in decreased expression of FABP4 mRNA	26210822
D001335	Vehicle Emissions	Vehicle Emissions results in decreased methylation of FABP4 gene	25560391
D015215	Zidovudine	Zidovudine affects the expression of FABP4 mRNA	20032539
D015032	Zinc	IL6 promoter polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA]	18316168
D015032	Zinc	MT1A gene polymorphism affects the reaction [Zinc results in decreased expression of FABP4 mRNA]	18316168
D015032	Zinc	Zinc results in decreased expression of FABP4 mRNA	18316168
D015032	Zinc	Zinc deficiency results in increased expression of FABP4 mRNA	11717422
D015054	Zymosan	Zymosan results in increased expression of FABP4 mRNA	15705927
D015054	Zymosan	Zymosan results in increased expression of FABP4 protein	15705927

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0005324	long-chain fatty acid transporter activity	-	ISS	-
GO:0005504	fatty acid binding	-	TAS	2481498
GO:0036041	long-chain fatty acid binding	-	ISS	-
GO:0051427	hormone receptor binding	-	IEA	-

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0001816	cytokine production	-	IEA	-
GO:0006469	negative regulation of protein kinase activity	-	IEA	-
GO:0015909	long-chain fatty acid transport	-	ISS	-
GO:0019433	triglyceride catabolic process	-	TAS	-
GO:0042632	cholesterol homeostasis	-	IEA	-
GO:0045892	negative regulation of transcription, DNA-templated	-	IEA	-
GO:0050729	positive regulation of inflammatory response	-	IEA	-
GO:0050872	white fat cell differentiation	-	IEA	-
GO:0050873	brown fat cell differentiation	-	IEA	-
GO:0071285	cellular response to lithium ion	-	IEA	-
GO:0071356	cellular response to tumor necrosis factor	-	IEA	-

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0005634	nucleus	-	ISS	-
GO:0005737	cytoplasm	-	ISS	-
GO:0005737	cytoplasm	-	TAS	16130169
GO:0005811	lipid droplet	-	TAS	-
GO:0005829	cytosol	-	TAS	-
GO:0070062	extracellular exosome	-	HDA	23533145

KEGG ID	KEGG Term
hsa03320	PPAR signaling pathway

Reactome ID	Reactome Term	Evidence
R-HSA-1266738	Developmental Biology	IEA
R-HSA-1266738	Developmental Biology	TAS
R-HSA-1430728	Metabolism	IEA
R-HSA-1430728	Metabolism	TAS
R-HSA-163560	Triglyceride catabolism	IEA
R-HSA-163560	Triglyceride catabolism	TAS
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	IEA
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	TAS
R-HSA-556833	Metabolism of lipids	IEA
R-HSA-556833	Metabolism of lipids	TAS
R-HSA-8979227	Triglyceride metabolism	IEA
R-HSA-8979227	Triglyceride metabolism	TAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal
22706792	Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes. (2012 Aug)	Djousse L	Lipids
22584136	Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults. (2012 Aug)	Djousse L	Diabetes Care